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Surface oxideThe European chemical framework REACH requires that hazards and risks posed by chemicals, including
alloys and metals, that are manufactured, imported or used in different products (substances or articles)
are identiﬁed and proven safe for humans and the environment. Metals and alloys need hence to be
investigated on their extent of released metals (bioaccessibility) in biologically relevant environments.
Read-across from available studies may be used for similar materials. This study investigates the release
of molybdenum and iron from powder particles of molybdenum metal (Mo), a ferromolybdenum alloy
(FeMo), an iron metal powder (Fe), MoO2, and MoO3 in different synthetic body ﬂuids of pH ranging from
1.5 to 7.4 and of different composition. Spectroscopic tools and cyclic voltammetry have been employed
to characterize surface oxides, microscopy, light scattering and nitrogen absorption for particle character-
ization, and atomic absorption spectroscopy to quantify released amounts of metals. The release of
molybdenum from the Mo powder generally increased with pH and was inﬂuenced by the ﬂuid compo-
sition. The mixed iron and molybdenum surface oxide of the FeMo powder acted as a barrier both at
acidic and weakly alkaline conditions. These ﬁndings underline the importance of the surface oxide char-
acteristics for the bioaccessibility of metal alloys.
 2015 The Authors. Published by Elsevier Inc. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
REACH (Registration, Evaluation, Authorisation and Restriction
of Chemicals) is a European Chemicals Directive ﬁrst implemented
in July 2007. Its aim is to evaluate, document and restrict the appli-
cation and progression of chemicals manufactured and processed
in the European Union in quantities that exceed 1 tonne per com-
pany and year (EC, 2007). Within REACH, metals are considered as
substances for which registration dossiers have to be submitted.
Such dossiers include the assessment of the toxicological and eco-
toxicological hazard proﬁle, for which the speciﬁc bioaccessibility
in biological ﬂuids plays an important role. Bioaccessibility is here
deﬁned as the pool of released metals from a metal or alloy that
potentially can become available for absorption by an organism
and is measured as the total amount of released metal species in
solution after separation from the powder particles. The bioavail-
able fraction of released metal species in solution may besigniﬁcantly lower compared with the total concentration.
However, this was not studied within the scope of this paper.
Alloys are generally considered as special mixtures under
REACH, for which no registration dossiers need to be prepared.
So far, very few alloys on the market have been investigated indi-
vidually. An alloy is as ‘‘a metallic material, homogeneous on a
macroscopic scale, consisting of two or more elements so combined
that they cannot be readily separated by mechanical means’’ (EC,
2009). An alloy is hence totally different from a chemical mixture.
One or several elements are intentionally added to the base ele-
ment, which constitutes the largest percentage of the material, to
gain speciﬁc mechanical or physico-chemical properties compared
with its pure alloy components. These changes in intrinsic proper-
ties make any translation, such as metal release rates of individual
elements to an alloy of the same elements inaccurate and irrele-
vant. As a result, properties of alloys are in need of evaluation
based on its alloy speciﬁc characteristics, and not on its pure con-
stituent metals. Potential health risks of alloys have in some cases
been estimated via read-across from the properties of the respec-
tive pure metals. However recent studies show that the surface
properties of alloys are more important than their bulk
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erroneous (Hedberg et al., 2013; Herting et al., 2005; Hillwalker
and Anderson, 2014; Stockmann-Juvala et al., 2013).
Metal release from metals and alloys, without contribution of
wear, is mainly governed by oxidation of the metal (corrosion)
and of chemical dissolution of the surface oxide. These processes
depend on the passive properties of the surface oxide (hinders cor-
rosion) and, among others, the pH and metal complexation capac-
ity of the surrounding ﬂuid (Hedberg et al., 2011b; Hedberg and
Midander, 2014; Mazinanian et al., 2015). Available corrosion
and metal release studies in the literature on
molybdenum-containing alloys are mainly focused on alloys (and
metals) commonly used in technical or medical applications (e.g.
corrosion-resistant stainless steel or implants) (Cobb and
Schmalzreid, 2006; Hanawa, 2004; Hedberg and Odnevall
Wallinder, 2014; Hedberg et al., 2014; Hillwalker and Anderson,
2014; Ichinose et al., 2003; Karimi et al., 2012; Lewis et al., 2005;
Metikoš-Hukovic´ et al., 2006; Okazaki and Gotoh, 2005, 2008;
Öztürk et al., 2006; Wataha, 2000). However, metal release data
from molybdenum-containing biomedical implants may not nec-
essarily follow similar trends as observed for pure molybdenum
metal or ferromolybdenum alloys, as the corrosion properties of
these materials are largely different (Hodgson et al., 2004;
Kocijan et al., 2004). Mechanistic metal release investigations of
molybdenummetal, ferromolybdenum alloys, or molybdenum oxi-
des are scarcely reported in the scientiﬁc literature, despite their
increasing use in different applications during the last decades.
Molybdenum or molybdenum oxide nanoparticles are for example
used for bio-diagnostics and energy storage applications as well as
in polymers (Chan et al., 2005; Lee et al., 2009; Sengupta et al.,
2014). Molybdenum shows relatively low acute toxicity, when
taken up via the oral, dermal or inhalation route (OECD CoCAM
programme, 2013).
The aim of this study is to correlate particle characteristics and
surface composition with the extent of metal release from
micron-sized powder particles of molybdenum (Mo) metal, iron
(Fe) metal, and a ferromolybdenum (FeMo) alloy into ﬁve synthetic
body ﬂuids of relevance for the human exposure routes of dermal
contact, inhalation and ingestion. Parallel comparative studies
were performed on MoO2 and MoO3 powder particles.2. Materials and methods
2.1. Investigated particles
This investigation includes the following micron-sized powder
particles; (i) molybdenum (Mo) metal (>99.95 wt%), CAS No.
7439-98-7, Batch No. C198, produced by CM CHEMIEMETALL
GmbH, Bitterfeld, Germany, (ii) a ferromolybdenum (FeMo) alloy
(Mo content 69.8 wt%), CAS No. 94277-04-0, Batch No.
1010/07/2, produced by Treibacher Industrie AG,
Treibach-Althofen, Germany, (iii) iron metal (Fe, >99.8 wt%), CAS
No. 7439-89-6, Batch No. 1946672, produced by Höganäs AB,
Höganäs, Sweden, (iv) molybdenum(IV)oxide (MoO2, >99.99 wt%),
CAS No. 18868-43-4, Batch No. D1308 DRO, produced by CM
CHEMIEMETALL GmbH, Bitterfeld, Germany, and (v)
molybdenum(VI)oxide (MoO3, >99.99 wt%), CAS No. 1313-27-5,
Batch No. RTPOC0080G, produced by Climax Molybdenum
Company, Rozenburg/Rotterdam, Netherlands.2.2. Cyclic voltammetry using a graphite paste electrode
Each molybdenum-containing powder (Mo, FeMo, MoO2, MoO3)
was mixed with graphite powder (natural, briquetting grade, 100
mesh, 99.9995% (metal basis), UCP-1 grade, Ultra ‘‘F’’ grade, LotNo. 61200620, Alfa Aesar, Sweden) in a ratio of 100 mg graphite
and 1, 5, or 10 mg metal/alloy/oxide powder. This mixture was
gently pressed and mixed with a pestle. A few drops of the elec-
trolyte [8 M NaOH (pH 13.6), a solution of sodium acetate/acetic
acid (0.1 M sodium acetate, 0.1 M acetic acid, pH 4.62), or 1 M
HCl (pH 0)] were added to obtain a paste. The paste was positioned
into a small (Ø 1.9 cm, height 7.0 cm) glass container connected
with a platinum wire to act as the working electrode. The counter
electrode (a platinum wire wrapped around the reference elec-
trode) and the reference electrode (Ag/AgCl sat. KCl) were posi-
tioned approximately 1 cm from the graphite paste in the
electrolyte. The system was, prior to the measurements, allowed
to equilibrate before determining the open circuit potential (OCP)
for 300 s (or until the change of OCP was less than 1 lV/s). The
potential was then swept cathodically (to more negative poten-
tials) starting at the OCP at a rate of 0.0005 V/s toward a potential
of approximately 1.4 V (vs. Ag/AgCl sat. KCl), after which the
potential was swept anodically until a potential of approximately
+0.2 V.
2.3. Raman spectroscopy
Raman spectroscopy measurements were conducted using a
Horiba HR800 Raman (Yvon Jobin) instrument using a 785 nm
laser and an Olympus 50X objective. The laser power was attenu-
ated to avoid sample damage. A visual inspection (optical micro-
scope) was made prior to, and after each measurement, to ensure
minimized sample destruction (via oxidation by the laser). In the
case of visible sample destruction, the spectrumwas not taken into
account. Presented results are based on average spectra accumu-
lated for 35 s at 3–5 different sample locations (MoO2, FeMo), or
one sample location (Mo, MoO3 – no signal for Mo, very strong sig-
nal for MoO3). No sufﬁcient signal was obtained for the Fe powder,
even with a 514 nm laser, a 100X objective, and an accumulation
time of 60 s, and without any laser attenuation.
2.4. X-ray photoelectron spectroscopy
With X-ray photoelectron spectroscopy (XPS) using a Kratos
AXIS UltraDLD X-ray photoelectron spectrometer (Kratos
Analytical, Manchester, UK) driven by a monochromatic 150 W
Al X-ray source, the outermost (approx. 5 nm) surface of the pow-
der particles was investigated. The analyzed areas were approxi-
mately sized 700  300 lm. Wide spectra measurements were
performed to probe elements in the top surface of the powder par-
ticles. With a pass energy of 20 eV, detailed spectra for the main
compositional elements of each powder, carbon (C 1s), oxygen (O
1s), nitrogen (N 1s), iron (Fe 2p) and molybdenum (Mo 3d) were
obtained. The powders were mounted on copper tape to ﬁx them
against diffusion in the applied vacuum inside the ultra-high vac-
uum instrumental chamber. All binding energies were corrected
to the carbon C 1s contamination peak at 285.0 eV. All peak areas
were determined by assigning a linear base line. For the calculation
of atomic ratios of oxidized metal and oxygen, the metal peak (only
detected for Mo at 228.4 ± 0.4 eV) was subtracted. Oxygen con-
nected to any oxidized carbon compounds from the ambient air
was not subtracted, however, its contribution was considered
small due to the lack of (Mo-metal powder) or minor presence of
oxidized carbon peaks (FeMo alloy, MoO2, and MoO3 powders).
2.5. Measurement of speciﬁc surface area by nitrogen adsorption
The surface area to weight ratio (speciﬁc surface area) of each
powder was estimated using the Brunauer–Emmet–Teller method
(Brunauer et al., 1938) (Micromeritics GEMINI V) that measures
the adsorbed amount of nitrogen at cryogenic conditions. The
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and at ﬁve different local positions for each powder (standard
BET method). The standard deviation was less than 1% for the
measurements.
2.6. Light scattering
The particle size distribution of each powder was determined in
phosphate buffered saline (PBS, pH 7.4, see Section 2.8) using low
angle laser light scattering (Malvern Mastersizer 2000, with a
Hydro SM dispersion unit). Refractive indexes for molybdenum
(3.71) and water (1.33, the solvent for the test media) for Mo,
FeMo, MoO2, and MoO3 powders, and refractive indexes for iron
(2.86) and water for the Fe powder were used as input parameters
for the calculation of the size distribution by volume. Data is pre-
sented as average numbers with standard deviation of at least
three discrete measurements of each powder.
The particle size distribution of each powder was furthermore
determined at dry conditions for the Fe metal powder (CILAS
1090D, at an air stream pressure of 500 mbar) and the Mo, FeMo,
MoO2, and MoO3 powders (Malvern Mastersizer MAM2461, air
pressure 1500 mbar) using the Fraunhofer theory.
2.7. Scanning electron microscopy
Particle morphologies were studied using a tabletop scanning
electron microscope (SEM) with backscattered electron analysis
(Hitachi TM-1000). The powders were ﬁxed on carbon tape to
avoid dispersion inside the instrument chamber and to assure
appropriate conduction.
2.8. Exposure to synthetic body ﬂuids
Triplicate samples of each powder were exposed for 2 and 24 h
to each of the ﬁve synthetic body ﬂuids (Table 1) at a ratio of
5 ± 0.5 mg particles in 50 mL solution (0.1 g/L) in closed PMP
Nalgene jars positioned in a Stuart platform-rocker incubator
(25 cycles/min of bi-linear shaking) at 37 ± 0.5 C. Blank samples
(without powders) were run in parallel for each powder, solution,
and exposure time. Exposures of the MoO3 powder were made at a
higher loading (50 ± 1 mg in 50 mL solution), which theoreticallyTable 1
Composition (g/L), initial, and ﬁnal pH of the ﬁve synthetic body ﬂuids.
Chemical GST
MgCl2 –
NaCl –
KCl –
Na2HPO4 –
KH2PO4 –
Na2SO4 –
CaCl22H2O –
C2H3O2NaH2O (sodium acetate) –
NaHCO3 –
C6H5Na3O72H2O (sodium citrate) –
NaOH –
Citric acid –
Glycine –
C4H4O6Na22H2O (Na2Tartrate2H2O) –
C3H5NaO3 (NaLactate) –
C3H5O3Na (NaPyruvate) –
CH3CHOHCO2H (lactic acid) –
(NH2)2CO (urea) –
HCl (25%) 4.0
Initial pH (prior to exposure) 1.7–1.8
Final pH (after exposure) – Mo, Fe, and FeMo 1.5–1.8
Final pH (after exposure) – MoO2 and MoO3 1.5–1.6
GST – artiﬁcial gastric solution; ALF – artiﬁcial lysosomal ﬂuid; ASW – artiﬁcial sweat;can suppress the extent of released molybdenum due to effects
of particle agglomeration and chemical equilibrium compared with
lower loadings (Hedberg and Odnevall Wallinder, 2012; Midander
et al., 2006). However, since the MoO3 powder completely dis-
solved in some ﬂuids and released most of its molybdenum con-
tent, compared with the other powders, the difference in loading
is not considered to inﬂuence any comparison with the other pow-
ders of this study. After exposure, the test ﬂuid was separated from
the powder particles by centrifugation at 3000 r.p.m. (704 r.c.f.) for
10 min. The supernatant solution, free of particles, was acidiﬁed to
a pH less than 2 (not needed in the case of artiﬁcial gastric ﬂuid)
with 65% ultrapure HNO3 prior to solution analysis (a standard
procedure for metal analysis and conservation of samples). All ves-
sels for exposure, centrifugation and storage were acid-cleaned in
10% HNO3 for at least 24 h, rinsed four times with ultra-pure water,
and dried in ambient laboratory air to minimize the risk of
contamination.
Five synthetic body ﬂuids were selected:
 Phosphate-buffered saline (PBS, pH 7.2–7.4), a standard physio-
logical ﬂuid that mimics the ionic strength of human blood
serum.
 Gamble’s solution (GMB, pH 7.4), mimics the interstitial ﬂuid
within the deep lung under normal health conditions
(Stopford et al., 2003).
 Artiﬁcial sweat (ASW, pH 6.5), simulates the hypoosmolar ﬂuid,
linked to hyponatraemia (loss of Na+ from blood), which is
excreted from the body upon sweating. The ﬂuid is recom-
mended in the available standard for testing of nickel release
from nickel containing products (CEN, 2011).
 Artiﬁcial lysosomal ﬂuid (ALF, pH 4.5), simulates intracellular
conditions in lung cells occurring in conjunction with phagocy-
tosis and represents relatively harsh conditions (de Meringo
et al., 1994; Hillwalker and Anderson, 2014).
 Artiﬁcial gastric ﬂuid (GST, pH 1.5), mimics the very harsh diges-
tion setting of high acidity in the stomach (Hamel et al., 1998).
2.9. Atomic absorption spectroscopy and data presentation
Total concentrations of released molybdenum in solution were
analyzed by atomic absorption spectroscopy (AAS) using aALF ASW PBS GMB
0.050 – – 0.095
3.21 5.0 8.77 6.02
– – – 0.298
0.071 – 1.28 0.126
– – 1.36 –
0.039 – – 0.063
0.128 – – 0.368
– – – 0.700
– – – 2.60
0.077 – – 0.097
6.00 – – –
20.8 – – –
0.059 – – –
0.090 – – –
0.085 – – –
0.086 – – –
– 1.0 – –
– 1.0 – –
– – – –
4.5 6.4–6.6 7.2–7.3 7.3–7.4
4.4–4.5 5.6–6.5 7.2–7.4 7.6–8.4
4.4–4.5 3.2–6.2 5.7–7.3 6.6–8.7
PBS – phosphate buffered saline; GMB – Gamble’s solution.
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(GF-AAS, lg/L, ppb range). Calibration standards with molybde-
num concentrations of 40, 120 and 360 mg/L were prepared using
1% HNO3 to mimic the acidic condition of acidiﬁed solution sam-
ples for analysis when using the reducing N2O/acetylene ﬂame.
0.5% AlCl3 was added to both the standards and the samples for
molybdenum analysis in order to avoid interferences. Quality con-
trols (in 1% HNO3) were performed every third sample to ensure
accurate and reliable data. Two matrix modiﬁers, palladium- and
magnesium nitrate and calibration standards with molybdenum
concentrations of 10, 30, and 100 lg/L were used for the GF-AAS
analysis. Since very stable complexes are formed in the graphite
furnace, the cleanout temperature was set to 2500 C, the time
for atomization to 5 s, and the cleanout time to 7 s. Quality controls
were performed every ninth sample. Calibration standards with
iron concentrations of 1, 5, and 10 mg/L, or 10, 30, and 100 mg/L
(if the sample concentration exceeded 10 mg/L) were used for
the air/acetylene ﬂame analysis of iron (FeMo and Fe powders).
The limits of detection, calculated as average blank values plus
3 times the highest standard deviation of the blanks in each solu-
tion, were between 1.0 (in PBS) and 4.4 lg/L (in ALF) for molybde-
num analyzed using the graphite furnace mode, between 51 (ALF)
and 75 lg/L (GMB) for molybdenum analyzed in the ﬂame mode,
and between 53 (GST) and 121 (ALF) lg/L for iron analyzed in
the ﬂame mode. All reported values are based on concentrations
that are signiﬁcantly higher than their corresponding limits of
detection. Iron released from the Fe metal powder was below the
limit of detection for the PBS and GMB ﬂuids (both pH 7.4) and
similar to the limit of detection for the ASW ﬂuid after 2 h of expo-
sure (pH 6.5), indicated in Fig. 3.
Release data is presented as the measured release of molybde-
num normalized to the particle content of molybdenum (wt%), or
the measured release of iron normalized to the particle content
of iron (wt%), as follows:
Aqueous metal concentration gL
   Volumeð0:05 LÞ
Sample massðgÞ  x  100 ð1Þ
With x = 1 (Mo and Fe metal powders), 0.698 (molybdenum
content of the FeMo alloy powder), 0.302 (iron content of the
FeMo alloy powder), 0.750 (molybdenum content of the MoO2
powder), and 0.667 (molybdenum content of the MoO3 powder).3. Results
3.1. Particle and surface characterization
Measured speciﬁc surface areas, including surface pores, are
compiled for each powder in Table 2. These areas increased accord-
ing the following sequence: Fe < FeMo < Mo < MoO2 < MoO3. An
increased speciﬁc surface area is normally correlated with reducedTable 2
BET speciﬁc surface area (m2/g) of the different powders investigated (relative
standard deviation <1%), and 10, 50, and 90 vol% cut-off values (lm) for each powder
when immersed in PBS (relative standard deviation <10%), and at dry conditions
(relative standard deviation <21%).
Powder Mo Fe FeMo MoO2 MoO3
BET(m2/g) 0.225 0.032 0.109 1.18 2.97
Immersed in PBS d0.1 (lm) 8.75 50.4 8.50 12.5 1.18
d0.5 (lm) 23.9 110 72.2 216 129
d0.9 (lm) 56.9 215 181 416 244
Dry d0.1 (lm) 3.70 50.7 32.6 5.70 21.3
d0.5 (lm) 8.40 96.6 98.9 229 195
d0.9 (lm) 15.5 177 176 402 365particle size (unless large contribution of surface pores). The size
distribution cut-off values (by volume) in PBS and at dry conditions
are also included in Table 2. The SEM investigation and dry size dis-
tribution measurements revealed particle sizes typically smaller
than 10 lm for the Mo metal powder. However, their size in PBS
appeared larger, most probably as a result of agglomeration in
solution. The FeMo alloy powder revealed relatively large particles,
sized around 100 lm based on SEM imaging, but also signiﬁcantly
smaller particles as reﬂected in the size distribution measurements
in PBS, Table 2. The Fe metal powder showed a relatively narrow
size distribution (both at dry conditions and in PBS, Table 2) with
an average size of approximately 100 lm. As evident from SEM
imaging, Fig. 1, the molybdenum oxide powders formed agglomer-
ates both in solution and at dry conditions. The MoO3 powder
showed smaller particles sizes when immersed in PBS compared
with dry conditions.
The surface or bulk oxides of the powder particles were inves-
tigated by means of Raman spectroscopy (sensitive to oxides, but
not to metals), by XPS (approx. 5 nm surface sensitivity), and cyclic
voltammetry (able to distinguish between different oxides). Raman
spectroscopy conﬁrmed the bulk oxide composition of MoO2 and
MoO3 for the two oxide powders, respectively (Table 3). The sur-
face oxide of the FeMo alloy powder did neither contain MoO3
nor hematite (a-Fe2O3), but a mixed Fe(III)/Mo(VI)-oxide, possibly
similar to ferrimolybdite (Fe2(MoO4)3n(H2O)) (Table 3).
Except for adventitious carbon present at the surface on all
powders, the main elements of each powder were observed in
the outer layer by means of XPS. Observed binding energies are
compiled in Table 4. Particles of both the Mo and the FeMo powder
revealed thin (a few nm) surface oxides, as evident from peaks
assigned as metallic Mo, Table 4. Mo(VI), the most oxidized form
of molybdenum, was observed at the outermost surface on powder
particles of MoO2, Mo, and FeMo. Oxidized iron in the outermost
surface was observed for the FeMo and Fe powders.
Cyclic voltammetry using a graphite paste electrode was
employed in 8 M NaOH (pH 13.6), and acetate buffer (pH 4.6) for
all molybdenum-containing powders (for selected powders also
in 1 M HCl, pH 0) in order to investigate possible solid/solid trans-
formations (from one oxide to another) or their dissolution proper-
ties. One reduction peak was observed for FeMo powder particles
in 8 M NaOH at approx. 1.2 V (Ag/AgCl) and two oxidation peaks
at approx. 0.9 and 0.8 V, corresponding to trivalent iron oxide
(Hedberg et al., 2012; Linhardt, 1998; Neugebauer et al., 1981).
These observations were not reproducible. No peaks corresponding
to any solid/solid transformation were observed for any of the
other measurements, powders, or electrolytes. The dissolution
potentials for the Mo metal powder were observed at 0.6 V (vs.
Ag/AgCl sat. KCl) in 8 M NaOH and at 0 V in acetate buffer.
Oxidative dissolution of the powders took place in the different
solutions in the following order:
 8 M NaOH: FeMo (0.6 V) Mo (0.6 V) > MoO2
(0.1 V) > MoO3 (none).
 Acetate buffer: FeMo (0.2 V) > Mo (0 V) > MoO2 (0.3 V) > MoO3
(none).
Dissolution in 1 M HCl was only examined for the MoO2 powder
that dissolved at 0.25 V.
3.2. Metal release in synthetic biological ﬂuids of varying pH and metal
complexation capacity
Amounts of molybdenum in solution released from powder par-
ticles of Mo, FeMo, MoO2 and MoO3 exposed for 2 and 24 h in the
different synthetic body ﬂuids are presented in Fig. 2. The Mo and
FeMo powders showed strongly reduced release rates with time
Fig. 1. SEM images of powder particles of Mo, FeMo, Fe, MoO2 and MoO3.
Table 3
Observed Raman bands (cm1) and their assignments for each powder. No informa-
tion could be obtained for the Mo and Fe metal powders.
Powder Observed Raman bands
(cm1)
Assignment (reference)
FeMo 218 s, 284 s, 350 w, 400 w,
600 w, 780–800 m br, 880
w, 923 vs
Possibly ferrimolybdite,
Fe2(MoO4)3n(H2O) (Kerr et al.,
1963; Sejkora et al., 2014)
MoO2 210 m, 229 m, 350 m, 363 s,
466 m, 490 m, 560 w, 580 w,
738 s
MoO2 (Fleischer and Pabst, 1981;
Kruglova et al., 1980; Kumari et al.,
2007)
MoO3 153 s, 240 m, 283 s, 340 m,
380 m, 670 m, 819 vs, 994 s
MoO3 (Anthony et al., 1990;
Kihlborg, 1963; Mestl et al., 1994;
Solferino and Anderson, 2012)
vs – very strong, s – strong, m – moderate, w – weak, br – broad.
Table 4
Binding energiesa (eV) of main peaks of Mo 3d5/2, O 1s and Fe 2p3/2 observed by
means of XPS and their assignments.
Mo
3d5/2
O 1sb Fe
2p3/2
Assignment (reference)
Mo 228.6;
233.2
531.0 – Mo metal (Werfel and Minni, 1983)
Mo(VI) (Anwar et al., 1989; Colton et al.,
1978)
Fe – 530.7 711.9 Fe(ox) (Fujii et al., 1999; Grosvenor et al.,
2004)
FeMo 228.0;
232.6
530.8 711.2 Mo metal (Werfel and Minni, 1983)
Mo(VI) (Anwar et al., 1989; Colton et al.,
1978)
Fe(ox) (Fujii et al., 1999; Grosvenor et al.,
2004)
MoO2 229.9;
233.1
530.9 – Mo(IV) (Colton et al., 1978)
Mo(VI) (Anwar et al., 1989; Colton et al.,
1978)
MoO3 232.6 530.4 – Mo(VI) (Anwar et al., 1989; Colton et al.,
1978)
a Measurements from one surface area sized approximately 300  700 lm.
b The contribution of oxygen related to oxidized carbon constituents in the sur-
face oxide was minor.
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(pH 1.5) and GMB (pH 7.4). Reduced release rates with time were
also observed for the MoO2 powder. From Fig. 3, it can clearly beseen that the FeMo alloy powder did neither behave like the Fe
metal powder nor like the Mo metal powder. The released amount
of iron from the Fe metal powder was strongly pH-dependent with
a high release into GST (pH 1.5) and non-detectable release into the
neutral or weakly alkaline ﬂuids of PBS and GMB (both pH 7.4). The
release of molybdenum from the Mo powder showed the opposite
pH-dependence (with the exception for the GMB ﬂuid). Mo parti-
cles were dissolved up to 6% in PBS, up to 2% in ASW and less than
1% in GST, ALF and GMB. In contrast, the highest total amount of
released metals in solution (Fe + Mo) was observed in ASW (pH
6.5) for the FeMo alloy powder. The corresponding release in the
other ﬂuids (GST, ALF, PBS and GMB) of both higher and lower
solution pH was 4–20-fold lower, Fig. 3. Molybdenum (per molyb-
denum content in the FeMo powder) was dissolved up to 13% in
ASW, about 2% in PBS and ALF, and less than 1% in GMB and GST.
More iron compared with molybdenumwas released at acidic con-
ditions (GST), and more molybdenum compared with iron was
released at higher pH values.4. Discussion
4.1. Characterization of the powders and their surface oxides
Since the micron-sized metal and alloy powders are signiﬁ-
cantly larger compared to the molybdenum oxide powders, they
should only be compared in terms of differences in surface oxide
composition and relative bioaccessibility in different solutions.
The MoO3 powder, with the largest speciﬁc surface area, revealed
smaller particle sizes when immersed in PBS compared with dry
conditions, most probably due to its dissolution in PBS, c.f.
Section 3.2. The effect of particle size and particle agglomeration
on bioaccessibility testing is discussed in Section 4.3.
To determine whether a Fe(III)/Mo(VI) surface oxide, such as
ferrimolybdite, was present on the FeMo powder or not, atomic
ratios of oxygen and molybdenum, measured by means of XPS,
were compared for the different powders. The atomic ratio was
MoO3.1 for the MoO3 powder, MoO2.4 for the MoO2 powder, and
MoO2.7 for the Mo metal powder. For the FeMo alloy powder, the
atomic ratio of oxygen to oxidized molybdenum was 7.2, and 4.4
for the ratio between oxygen and oxidized iron. These ratios are
signiﬁcantly higher compared with corresponding ratios of pure
molybdenum- or iron oxides (e.g., MoO3: 3; MoO2: 2; Fe2O3: 1.5;
Fig. 2. Released amounts of molybdenum (Mo) normalized to the powder particle content of molybdenum (wt%) for the Mo, FeMo, MoO2, and MoO3 powders exposed for 2
and 24 h in different synthetic body ﬂuids (GST – artiﬁcial gastric solution; ALF – artiﬁcial lysosomal ﬂuid; ASW – artiﬁcial sweat; PBS – phosphate buffered saline; GMB –
Gamble’s solution).
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stituent, such as ferrimolybdite (atomic ratios: O/Mo(ox) = 13;
O/Fe(ox) = 6.5). There is also a strong indication by means of
Raman spectroscopy for a Mo(VI)/Fe(III) phase on the FeMo pow-
der surface, such as ferrimolybdite. Single oxidic phases containing
Mo and Fe (e.g., MoO3, MoO2, Fe2O3, and FeO(OH)) can be excluded,
as judged from the Raman spectroscopy results.
To interpret the cyclic voltammetry measurements, available
pH-potential diagrams described in the literature were studied. It
is according to some reported pH-potential diagrams theoretically
possible that there is a solid/solid transformation upon oxidation
from Mo(0) or Mo(IV) to Mo(VI) in very acidic environments
(Besson and Drautzburg, 1960; Lu and Clayton, 1989; Pardo
et al., 2008). This was however discarded already in 1960 in a study
that showed direct oxidative dissolution of Mo to Mo(VI) (aq) at
acidic conditions (Besson and Drautzburg, 1960). These ﬁndings
have been conﬁrmed in more recent studies (Presuel-Moreno
et al., 2005). Cyclic voltammetry results of this paper could hence
not provide any further novel information on the surface oxides
of the investigated powders, and the dissolution potentials
observed were in agreement with some literature data on electro-
chemical dissolution of similar metals and oxides (Besson and
Drautzburg, 1960).Concluding the surface oxide characterization, the
molybdenum-containing powders tested in this study revealed
particle surfaces predominantly composed of Mo(VI)-species, the
most oxidized form of molybdenum. A Fe(III)/Mo(VI) oxide was
assigned as the main constituent of the surface oxide of the powder
particles of the FeMo alloy.
4.2. Metal release in synthetic biological ﬂuids of varying pH and metal
complexation capacity
The time periods for exposure in the biological ﬂuids were
selected to have some relevance for the inhalation/ingestion sce-
nario. The approximate time for the gastric phase of digestion is
about 2 h, and therefore this exposure time period was considered
relevant for testing in artiﬁcial gastric ﬂuid (Hamel et al., 1998).
The 24 h exposure was selected as it can be assumed that human
exposure to micron-sized particles lasts no longer than 24 h at
ambient conditions. The Mo and FeMo powders showed strongly
reduced release rates with time (amount of molybdenum released
per time unit), especially in GST (pH 1.5) and GMB (pH 7.4), indica-
tive of improved surface passivity/stabilization over time, or possi-
bly the occurrence of precipitation processes of released
molybdenum in solution. Reduced release rates with time were
Fig. 3. Release of molybdenum or iron normalized to the corresponding metal
particle content (wt%) for the Fe, FeMo, and Mo powders exposed for 2 and 24 h in
different synthetic body ﬂuids (GST – artiﬁcial gastric solution; ALF – artiﬁcial
lysosomal ﬂuid; ASW – artiﬁcial sweat; PBS – phosphate buffered saline; GMB –
Gamble’s solution). The lines are only guidance for the eye. <LOD – measured
concentrations below the limit of detection. The measured concentration of iron
was similar to the limit of detection in the case of released iron from the Fe metal
powder after 2 h in ASW.
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the initial dissolution of less chemically stable particles, or possibly
by the precipitation of released molybdenum in GST and/or GMB.
However, since no precipitation was observed for molybdenum
released from the MoO3 powder in GST or GMB, precipitation pro-
cesses are not considered as any main factors that explain the
strongly reduced release rates observed for the other powders.
Compared with the PBS ﬂuid of similar pH, the chemically complex
solution GMB, which contains relatively high amounts of carbon-
ate, has been shown able to passivate metal and metal oxidesurfaces and contribute with species that form complexes with
released metals in solution that may precipitate (Midander et al.,
2010). Low chemical and electrochemical release rates of molybde-
num metal and molybdenum oxides are expected at acidic pH
(GST, pH 1.5, and ALF, pH 4.5) based on thermodynamic delibera-
tions (Besson and Drautzburg, 1960; Lu and Clayton, 1989; Pardo
et al., 2008; Presuel-Moreno et al., 2005) and known chemical dis-
solution mechanisms of molybdenum oxides (Rollinson, 1975).
Relatively higher release rates of molybdenum in ASW (pH 6.5)
observed for the FeMo and MoO2 powders could be related to its
higher pH (compared with the GST and ALF solutions) and com-
plexation between lactate and Mo(VI) (Beltrán-Porter et al., 1983).
Bioaccessibility ﬁndings of Fe metal, Mo metal, and FeMo alloy
powders, Fig. 3, are in agreement with the chemical and electro-
chemical stability of iron (Pourbaix, 1984) and molybdenum
(Besson and Drautzburg, 1960; Lu and Clayton, 1989; Pardo
et al., 2008; Presuel-Moreno et al., 2005; Rollinson, 1975), and
partly related to the precipitation of released iron in solution at
these pH levels (evident from lower measured concentrations of
iron in solution after 24 h compared with 2 h of exposure for the
FeMo alloy powder, Fig. 3). These processes have previously been
described by the authors (Hedberg and Odnevall Wallinder,
2012). Since the surface of the FeMo alloy powder is composed
of a Fe(III)/Mo(VI)-oxide, dissolution of the oxide is inhibited in
both acidic and alkaline environments, Fig. 3, similar to ﬁndings
for the Fe/Cr-oxide on stainless steel (Schmuki, 2002; Sedriks,
1996). This explains the relatively high protection against electro-
chemically and chemically governed release of iron and molybde-
num into solution from the FeMo alloy powder in both acidic and
neutral/alkaline solutions.
4.3. Inﬂuence of powder characteristics and experimental conditions
on bioaccessibility
Comparisons between powders of metals, oxides and alloys
from a bioaccessibility perspective require that differences in par-
ticle and surface characteristics are considered (Hedberg et al.,
2013). For powder particles with very similar surface oxide charac-
teristics, a smaller particle size (larger speciﬁc surface area) gener-
ally results in a larger amount of released metals, and
normalization to the surface area is common. However, alloy pow-
ders often have surface oxides that are composed of several metals,
compositions that vary with the particle size and that depend on
the cooling rate and other conditions during particle production
(Hedberg et al., 2011a; Hedberg and Midander, 2014). Such differ-
ences have for example been shown to result in a signiﬁcantly
higher bioaccessibility (when normalized to the surface area of
the particles) for smaller sized stainless steel (AISI 316L) powder
particles compared with larger-sized particles of the same alloy
in ALF, a solution of high metal complexation capacity (pH 4.5),
whereas the opposite situation with higher bioaccessibility was
the case for larger compared with smaller sized particles of Fe
metal and Cr metal particles (due to particle agglomeration effects
in solution) (Hedberg et al., 2010a). The same stainless steel alloy
further revealed a lower bioaccessibility for the smaller-sized pow-
der compared with the larger-sized powder (when normalized to
the surface area) in non-complexing or neutral solutions such as
PBS (Hedberg et al., 2013). This behavior is explained by their sur-
face oxide characteristics with certain susceptibilities to
complexation-induced chemical dissolution or electrochemical
corrosion (Hedberg and Midander, 2014).
Besides the particle size that inﬂuences the surface oxide char-
acteristics, at least for alloy powders, the extent of agglomeration
in solution during bioaccessibility testing largely inﬂuences the
results. The degree of agglomeration depends on the powder char-
acteristics, primarily its isoelectric point, and on the solution
Fig. 4. Release of molybdenum or iron normalized to the corresponding metal particle content (wt%) for the Fe (a–b), FeMo (a–d), and Mo (c–d) powders exposed for 2 (a and
c) and 24 h (b and d) in different synthetic body ﬂuids of varying pH (pH 1.5, GST – artiﬁcial gastric solution; pH 4.5, ALF – artiﬁcial lysosomal ﬂuid; pH 6.5, ASW – artiﬁcial
sweat; pH 7.4, PBS – phosphate buffered saline; pH 7.4, GMB – Gamble’s solution). The arrows indicate changes of the pH during exposure. The measured concentration of
iron released from the Fe metal powder was similar to the limit of detection after 2 h in artiﬁcial sweat, and below the limit of detection in phosphate buffered saline and
Gamble’s solution.
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that inﬂuence attractive forces between particles (van Oss, 2006).
In this study, the highest extent of agglomeration was observed
for the MoO2 powder. The degree of particle agglomeration in solu-
tion was dissimilar among the different investigated powders.
Agglomeration is further inﬂuenced by the loading (powder
mass per solution volume), and sample preparation such as sonica-
tion of particle dispersions (Cronholm et al., 2011; Hedberg et al.,
2010a; Karlsson et al., 2013; Midander et al., 2006). The loading
affects further the chemical equilibrium between dissolved and
solid species, suppressing metal release at very high loadings.
Thus, these effects need to be considered in solubility studies.
Only relative comparisons between the powders are hence pos-
sible in this study due to their differences in speciﬁc surface areas
and extent of agglomeration in solution, which results in different
amounts of released molybdenum into solution per particle mass.
4.4. Implications for risk assessments of alloys
The strong non-linear inﬂuence of particle characteristics,
experimental conditions, and surface oxide characteristics of metal
or alloy powder on the extent of released metals into solution
mean that the bioaccessibility of a given metallic powder can vary
signiﬁcantly, depending on speciﬁc bulk and surface properties,
and experimental conditions would beneﬁt from standardization.
Prevailing experimental conditions, particle- and surface oxide
characteristics also inﬂuence the rate of particle dissolution. Therate of dissolution of pharmaceuticals or salts is often described
by the NoyesWhitney equation, which correlates to e.g. the surface
area of the interface between the dissolving substance and the sol-
vent, and to the diffusion coefﬁcient (Dokoumetzidis and
Macheras, 2006). However, this description is not applicable to
particles of passive metals and alloys as they have surface oxides
of different composition than in the bulk alloy, and that hinder dif-
fusion processes at room or body temperatures (Rapp, 1984).
Instead, metal release processes from powder particles of metals
and alloys in solution are predominantly the result of surface
defects, complexation-induced dissolution, and/or metastable cor-
rosion processes (Hedberg et al., 2012; Hedberg and Midander,
2014).
Alloy bioaccessibility (metal release) is, in the case of lack of
data, sometimes estimated from existing data on their pure metal
constituents, if available (EC, 2007). This approach has been shown
erroneous for alloys such as stainless steels, ferrochromium alloys,
and ferrosilicochromium alloys (Hedberg et al., 2013; Herting et al.,
2005; Hillwalker and Anderson, 2014; Midander et al., 2010;
Santonen et al., 2010; Stockmann-Juvala et al., 2013). A main rea-
son is that these alloys all have surface oxides that have different
properties compared with surface oxides of their individual metal
constituents, and that all alloy components may not be present in
the outermost surface oxide but may appear in adjacent alloy sur-
face layers beneath the oxide, or in the bulk alloy. Such alloys
reveal, compared with their pure alloy constituents, relatively
higher corrosion resistances in similar synthetic body ﬂuids as
Table 5
Average difference in iron released per iron content in the powder (wt%), and molybdenum released per molybdenum content in the powder (wt%), after 2 and 24 h of exposure in
the different synthetic body ﬂuids. Corresponding average difference presented as metal released per particle surface area (based on the speciﬁc surface area measured by the BET
method), in lg/cm2, is given in parentheses.
pH and
ﬂuid
2 h: Mo difference FeMo–Mo
powders
24 h: Mo difference FeMo–Mo
powders
2 h: Fe difference FeMo–Fe
powders
24 h: Fe difference FeMo–Fe
powders
1.5 (GST) 0.28 (+5.0) +0.35 (+10) 7.8 (315) 61 (2030)
4.5 (ALF) +0.06 (+3.4) +1.9 (+12) 2.9 (136) 28 (1008)
6.5 (ASW) +1.5 (+12) +10 (+8.5) +4.7 (+23) +6.2 (+74)
7.4 (PBS) +0.26 (+0.8) 3.9 (22) +0.79 (+5.8) +1.6 (+18)
7.4 (GMB) +0.27 (+1.6) +0.5 (0.6) +0.84 (+5.1) +0.05 (+4.3)
GST – artiﬁcial gastric solution; ALF – artiﬁcial lysosomal ﬂuid; ASW – artiﬁcial sweat; PBS – phosphate buffered saline; GMB – Gamble’s solution.
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into solution. For example, less than 0.3% of the particle mass of
powders of stainless steel, ferrochromium alloys, and ferrosilic-
ochromium alloys, compared with less than 100% for iron and
nickel metal powders, was released into solution when exposed
to the same biological ﬂuids as investigated in this study
(Hedberg et al., 2010b; Midander et al., 2010). In this study less
than 12% of the particle mass of the FeMo alloy powder was
released at similar conditions.
A comparison of released amounts of metals normalized by the
corresponding metal content of each powder, or to the speciﬁc sur-
face area of the powder particles, is compiled for the Fe, Mo, and
FeMo powders of this study in Figs. 3 and 4 and Table 5. Assuming
that the FeMo alloy (30.2 wt% Fe, 69.8 wt% Mo) would behave as a
mixture of its pure metal constituents, the estimated release of iron
and molybdenum (based on 24 h exposure data in wt%) would
become highly erroneous and deviate signiﬁcantly from the mea-
sured bioaccessibility. The release of iron from the FeMo alloy pow-
der would be highly overestimated in acidic solutions (15-fold in
GST, 6-fold in ALF)when compared to the Femetal powder, whereas
the release ofmolybdenumwouldbeunderestimatedat similar con-
ditions (2-fold in GST, 4-fold in ALF), Fig. 4. In neutral and alkaline
solutions, the release of iron would be highly underestimated
(8-fold in ASW, unlimited in PBS and GMB), and the release of
molybdenum under- or overestimated (5-fold underestimated in
ASW, 3-fold overestimated in PBS, and 4-fold underestimated in
GMB). This comparison clearly illustrates that the Fe(III)/Mo(VI) sur-
face oxide at the FeMo alloy particle surface hinders the release of
iron at acidic conditions, and possibly of molybdenum at alkaline
pH, but not in ASW (pH 6.5), despite the fact that the overall release
was not signiﬁcantly lower from the FeMo powder compared with
thepowders of its puremetal constituents. This is causedby the abil-
ity of such oxides on alloys to adjust their outermost oxide compo-
sition to the environment (Hedberg et al., 2013; Virtanen et al.,
2008). This example hence demonstrates that alloys do not behave
as their pure metal constituents, even if the alloy has a relatively
low corrosion resistance or exhibits similar extents of total metal
release compared with its pure metal constituents.
5. Conclusions
This study links particle characteristics and surface composition
of powder particles of Mo metal, Fe metal, a FeMo alloy, and oxides
of MoO2 and MoO3 with quantitative data after 2 and 24 h of expo-
sure to the release of molybdenum and iron in ﬁve synthetic body
ﬂuids of varying pH and metal complexation capacity relevant for
different human exposure routes including dermal contact, inhala-
tion and ingestion. The following main conclusions were drawn:
1. A Fe(III)/Mo(VI) oxide at the particle surface of the FeMo alloy
powder hindered the release of iron at acidic conditions and
possibly of molybdenum at weakly alkaline conditions, butnot at near neutral conditions (artiﬁcial sweat). Despite a total
amount of released metals in the same order of magnitude com-
pared with its pure alloy components, the released amount of
iron and molybdenum from the FeMo powder would be
strongly over- or underestimated if predicted from metal
release data of the pure elements, when exposed at similar
conditions.
2. Bioaccessibility of the FeMo alloy powder cannot be predicted
based on data from powder particles of its pure alloying
elements.
3. More molybdenumwas released at higher pH from powder par-
ticles of Mo metal and of oxides of MoO2 and MoO3. The weakly
alkaline Gamble’s solution (GMB, pH 7.4), which contains a sig-
niﬁcant amount of carbonates, most probably induced surface
passivation for most powders and/or precipitation of molybde-
num from solution, and thereby signiﬁcantly lower amounts of
released molybdenum compared with observations in the
weakly alkaline PBS solution of similar pH.
4. The Mo powder released lower amounts of molybdenum after
24 h compared with 2 h due to surface passivation/stabilization,
processes that were mostly pronounced in the acidic gastric
solution GST (pH 1.5) and in GMB (pH 7.4).
5. Molybdenumwas released from the Mo powder up to 6% in PBS,
up to 2% in ASW and less than 1% in GST, ALF and GMB. For the
FeMo powder, molybdenum was released up to 13% in artiﬁcial
sweat (ASW, pH 6.5), about 2% in PBS and ALF, and less than 1%
in GMB and GST.
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